- May 30, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Valstar
Synonyms :
valrubicin
Class :
Antineoplastics and Anthracycline
Dosage Forms & Strengths
Intravesical solution
40mg per ml
800
mg
intravesical once per week for about six weeks
Note:
Delayed administration at least two weeks after transurethral resection or fulguration
Retain the drug for two hours in bladder before voiding
After 2hrs patients should void
Dose Adjustments
Renal Dose Adjustments:
No data available
Liver Dose Adjustments:
No data available
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect
measles mumps and rubella vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect
measles mumps and rubella vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
when both drugs are combined, there may be increased toxicity of valrubicin
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of adverse effects
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
it may increase the levels of serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Substrates
it may increase the levels of serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Substrates
it may increase the levels of serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Substrates
it may increase the levels of serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Substrates
it may increase the levels of serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Substrates
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may reduce the therapeutic effect of typhoid Vaccine
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may decrease the serum concentration
may decrease the serum concentration
Adverse drug reactions:
Frequency defined
>10%
Bladder pain
Bladder spasm
Cystitis
Dysuria
Hematuria
Urinary incontinence
UTI
Urinary frequency
Urinary urgency
1-10%
Abd pain
Anemia
Back pain
Chest pain
Dizziness
Diarrhea
Headache
Nausea
Malaise
Pneumonia
Rash
Urinary retention
Vomiting
Vasodilation
Frequency not defined
Asthenia
Pregnancy warnings:
Breastfeeding warnings:
Pregnancy Categories:
Patient Information Leaflet
Generic Name: valrubicin (Rx)
Pronounced: val ROO bi sin
Why do we use valrubicin?
Valrubicin is an antineoplastic drug used to treat bladder cancer. Most people do not respond to valrubicin, so they opt for surgery for the removal of the bladder to prevent metastasis
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
